This is to inform you that Outcome of the Board Meeting of the Company held on Friday 23rd May 2025 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Limited (formerly Sun and Shine Worldwide Limited) reported audited financial results for FY25 with zero revenue from operations and a net loss of Rs. 58.38 lakhs, widening from a Rs. 19.62 lakhs loss in FY24. The company booked an exceptional item of Rs. 17.16 lakhs on account of a SEBI penalty. Total income for the year was negative Rs. 33.34 lakhs, while total expenses stood at Rs. 7.88 lakhs. The statutory auditor (Rishi Sekhri and Associates) issued an unmodified (clean) opinion on the results. Cash flow from operating activities was sharply negative at Rs. 190.89 lakhs versus Rs. 4.54 lakhs in the previous year, and cash balance remained very thin at Rs. 0.77 lakhs.
The company continues to show no operating revenue and widening losses with deeply negative operating cash flows, which is a significant red flag for shareholders despite a clean audit opinion. Investors should view this stock with caution given the lack of business activity and depleting cash position.